Screener
Vaxcyte, Inc. PCVX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
| Line item | March 31,2026 | December 31, 2025 |
|---|---|---|
| Accrued expenses | 30,247 | 31,068 |
| Operating lease liabilities — current | 6,085 | 6,124 |
| Total current liabilities | 242,082 | 205,750 |
| Operating lease liabilities — long-term | 110,212 | 111,457 |
| Total liabilities | 352,294 | 317,207 |
| Commitments and contingencies (Note 6) | ||
| Stockholders' Equity | ||
| Preferred stock, $0.001 par value — 10,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s operating lease liabilities?
- Vaxcyte, Inc. (PCVX) reported operating lease liabilities of $110.21M in Q1 2026.
- How has Vaxcyte, Inc.'s operating lease liabilities changed year-over-year?
- Vaxcyte, Inc.'s operating lease liabilities increased by 35.9% year-over-year, from $81.08M to $110.21M.
- What is the long-term trend for Vaxcyte, Inc.'s operating lease liabilities?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s operating lease liabilities has grown at a 76.4% compound annual growth rate (CAGR), from $11.51M to $111.46M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Vaxcyte, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude